- 专利标题： Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
-
申请号： US11065531申请日： 2005-02-24
-
公开(公告)号： US20050245458A1公开(公告)日： 2005-11-03
- 发明人: Ashok Arasappan , F. Njoroge , Angela Padilla-Acevedo , Kevin Chen , Frank Bennett , Mousumi Sannigrahi , Stephane Bogen , Srikanth Venkatraman , Edwin Jao , Anil Saksena , Viyyoor Girijavallabhan
- 申请人： Ashok Arasappan , F. Njoroge , Angela Padilla-Acevedo , Kevin Chen , Frank Bennett , Mousumi Sannigrahi , Stephane Bogen , Srikanth Venkatraman , Edwin Jao , Anil Saksena , Viyyoor Girijavallabhan
- 专利权人： SCHERING CORPORATION
- 当前专利权人： SCHERING CORPORATION
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K38/04 ; C07D417/02 ; C07K5/02 ; C07K5/04 ; C07K5/06 ; C07K5/065 ; C07K5/08 ; C07K5/083 ; C12Q1/70 ; C07D43/02 ; C07D45/04
摘要：
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
IPC分类:
